Skip to main content
Erschienen in: The International Journal of Cardiovascular Imaging 1/2024

02.11.2023 | Research Article

Significantly elevated hepatic extracellular volume in adult patients with a Fontan circulation and its correlation with impaired functional capacity

verfasst von: Surachai Kongrat, Tananya Lueangklanlayanakhun, Varinsawat Prakongwong, Watcharee Prasertkulchai, Tarinee Tangcharoen

Erschienen in: The International Journal of Cardiovascular Imaging | Ausgabe 1/2024

Einloggen, um Zugang zu erhalten

Abstract

Fontan-associated liver disease is a major concern in patients who have undergone the procedure. Regular imaging of the liver is currently recommended for Fontan patients, but not other congenital heart diseases. The extracellular volume (ECV) of the liver obtained during CMR scanning and studies can show the high liver ECV in Fontan patients. However, the correlation between the liver ECV and the functional capacity of Fontan patients has not yet been reported. This study aimed to compare the liver ECV between Fontan patients and other congenital heart diseases with significant pulmonic regurgitation (PR) or tricuspid regurgitation (TR), and to evaluate the correlation between the liver ECV in adult Fontan patients and their functional capacity as well as clinical characteristics. Retrospective analysis of cardiovascular magnetic resonance imaging from patients with history of Fontan surgery between 2017 and 2021 were conducted. The clinical characteristics and liver ECV were evaluated and compared between patients and control group. Functional capacity was evaluated using a 6-min walk distance (6MWD). The correlation between the liver ECV and functional capacity was analyzed. 35 patients were enrolled in the study, including 13 Fontan patients, 12 Ebstein’s anomaly or repaired tetralogy of Fallot (rTOF) patients with significant PR or TR, and 10 patients for the control group. The liver ECV were significantly higher in Fontan patients compared with Ebstein’s anomaly/rTOF and the control group (41.% in Fontan group, 33.9% in Ebstein’s anomaly/rTOF, and 31.7% in control group with p = 0.01 and 0.0008 in Fontan vs. Ebstein’s anomaly/rTOF and Fontan vs. control group, respectively). In Fontan patients, there was a significant correlation between the liver ECV and the liver blood biochemistry with r = 0.879, p = 0.01 for AST/ALT ratio and r = 0.65, p = 0.005 for AST. The liver ECV was inversely correlated with the six-minute walk distance (r = -0.55, p = 0.02). The liver ECV in patients who had undergone Fontan operation showed a significantly elevated and has significantly inversed correlation with their functional capacity. These findings indicated that the liver ECV may be a potentialmarker for adverse clinical outcomes. However, due to small size population, further prospective study with larger number of patients may validate this findings.
Literatur
2.
Zurück zum Zitat d’Udekem Y, Iyengar AJ, Galati JC, Forsdick V, Weintraub RG, Wheaton GR et al (2014) Redefining expectations of long-term survival after the Fontan procedure: twenty-five years of follow-up from the entire population of Australia and New Zealand. Circulation 130(11 Suppl 1):S32–S38PubMed d’Udekem Y, Iyengar AJ, Galati JC, Forsdick V, Weintraub RG, Wheaton GR et al (2014) Redefining expectations of long-term survival after the Fontan procedure: twenty-five years of follow-up from the entire population of Australia and New Zealand. Circulation 130(11 Suppl 1):S32–S38PubMed
3.
Zurück zum Zitat Goldberg DJ, Surrey LF, Glatz AC, Dodds K, O’Byrne ML, Lin HC et al (2017) Hepatic fibrosis is universal following fontan operation, and severity is associated with time from surgery: a liver biopsy and hemodynamic study. J Am Heart Assoc 6:5CrossRef Goldberg DJ, Surrey LF, Glatz AC, Dodds K, O’Byrne ML, Lin HC et al (2017) Hepatic fibrosis is universal following fontan operation, and severity is associated with time from surgery: a liver biopsy and hemodynamic study. J Am Heart Assoc 6:5CrossRef
4.
Zurück zum Zitat Srinivasan A, Guzman AK, Rand EB, Rychik J, Goldberg DJ, Russo PA et al (2019) Percutaneous liver biopsy in Fontan patients. Pediatr Radiol 49(3):342–350CrossRefPubMed Srinivasan A, Guzman AK, Rand EB, Rychik J, Goldberg DJ, Russo PA et al (2019) Percutaneous liver biopsy in Fontan patients. Pediatr Radiol 49(3):342–350CrossRefPubMed
5.
Zurück zum Zitat Baumgartner H, De Backer J, Babu-Narayan SV, Budts W, Chessa M, Diller GP et al (2021) 2020 ESC Guidelines for the management of adult congenital heart disease. Eur Heart J 42(6):563–645CrossRefPubMed Baumgartner H, De Backer J, Babu-Narayan SV, Budts W, Chessa M, Diller GP et al (2021) 2020 ESC Guidelines for the management of adult congenital heart disease. Eur Heart J 42(6):563–645CrossRefPubMed
6.
Zurück zum Zitat Alsaied T, Moore RA, Lang SM, Truong V, Lubert AM, Veldtman GR et al (2020) Myocardial fibrosis, diastolic dysfunction and elevated liver stiffness in the Fontan circulation. Open Heart 7:2CrossRef Alsaied T, Moore RA, Lang SM, Truong V, Lubert AM, Veldtman GR et al (2020) Myocardial fibrosis, diastolic dysfunction and elevated liver stiffness in the Fontan circulation. Open Heart 7:2CrossRef
7.
Zurück zum Zitat Shiina Y, Inai K, Ohashi R, Nagao M (2020) Potential of liver T(1) mapping for the detection of fontan-associated liver disease in adults. Magn Reson Med Sci 20:295–302CrossRefPubMedPubMedCentral Shiina Y, Inai K, Ohashi R, Nagao M (2020) Potential of liver T(1) mapping for the detection of fontan-associated liver disease in adults. Magn Reson Med Sci 20:295–302CrossRefPubMedPubMedCentral
8.
Zurück zum Zitat de Lange C, Thrane KJ, Thomassen KS, Geier O, Nguyen B, Tomterstad A et al (2021) Hepatic magnetic resonance T1-mapping and extracellular volume fraction compared to shear-wave elastography in pediatric Fontan-associated liver disease. Pediatr Radiol 51(1):66–76CrossRefPubMed de Lange C, Thrane KJ, Thomassen KS, Geier O, Nguyen B, Tomterstad A et al (2021) Hepatic magnetic resonance T1-mapping and extracellular volume fraction compared to shear-wave elastography in pediatric Fontan-associated liver disease. Pediatr Radiol 51(1):66–76CrossRefPubMed
9.
Zurück zum Zitat de Lange C, Reichert MJE, Pagano JJ, Seed M, Yoo SJ, Broberg CS et al (2019) Increased extracellular volume in the liver of pediatric Fontan patients. J Cardiovasc Magn Reson 21(1):39CrossRefPubMedPubMedCentral de Lange C, Reichert MJE, Pagano JJ, Seed M, Yoo SJ, Broberg CS et al (2019) Increased extracellular volume in the liver of pediatric Fontan patients. J Cardiovasc Magn Reson 21(1):39CrossRefPubMedPubMedCentral
10.
Zurück zum Zitat Emamaullee J, Zaidi AN, Schiano T, Kahn J, Valentino PL, Hofer RE et al (2020) Fontan-associated liver disease: screening, management, and transplant considerations. Circulation 142(6):591–604CrossRefPubMedPubMedCentral Emamaullee J, Zaidi AN, Schiano T, Kahn J, Valentino PL, Hofer RE et al (2020) Fontan-associated liver disease: screening, management, and transplant considerations. Circulation 142(6):591–604CrossRefPubMedPubMedCentral
11.
Zurück zum Zitat Fratz S, Chung T, Greil GF, Samyn MM, Taylor AM, Valsangiacomo Buechel ER et al (2013) Guidelines and protocols for cardiovascular magnetic resonance in children and adults with congenital heart disease: SCMR expert consensus group on congenital heart disease. J Cardiovasc Magn Reson 15(1):51CrossRefPubMedPubMedCentral Fratz S, Chung T, Greil GF, Samyn MM, Taylor AM, Valsangiacomo Buechel ER et al (2013) Guidelines and protocols for cardiovascular magnetic resonance in children and adults with congenital heart disease: SCMR expert consensus group on congenital heart disease. J Cardiovasc Magn Reson 15(1):51CrossRefPubMedPubMedCentral
12.
Zurück zum Zitat Kim PK, Hong YJ, Im DJ, Suh YJ, Park CH, Kim JY et al (2017) Myocardial T1 and T2 mapping: techniques and clinical applications. Korean J Radiol 18(1):113–131CrossRefPubMedPubMedCentral Kim PK, Hong YJ, Im DJ, Suh YJ, Park CH, Kim JY et al (2017) Myocardial T1 and T2 mapping: techniques and clinical applications. Korean J Radiol 18(1):113–131CrossRefPubMedPubMedCentral
13.
Zurück zum Zitat Haaf P, Garg P, Messroghli DR, Broadbent DA, Greenwood JP, Plein S (2016) Cardiac T1 mapping and extracellular volume (ECV) in clinical practice: a comprehensive review. J Cardiovasc Magn Reson 18(1):89CrossRefPubMedPubMedCentral Haaf P, Garg P, Messroghli DR, Broadbent DA, Greenwood JP, Plein S (2016) Cardiac T1 mapping and extracellular volume (ECV) in clinical practice: a comprehensive review. J Cardiovasc Magn Reson 18(1):89CrossRefPubMedPubMedCentral
14.
Zurück zum Zitat Kazour I, Serai SD, Xanthakos SA, Fleck RJ (2018) Using T1 mapping in cardiovascular magnetic resonance to assess congestive hepatopathy. Abdom Radiol (NY) 43(10):2679–2685CrossRefPubMed Kazour I, Serai SD, Xanthakos SA, Fleck RJ (2018) Using T1 mapping in cardiovascular magnetic resonance to assess congestive hepatopathy. Abdom Radiol (NY) 43(10):2679–2685CrossRefPubMed
15.
Zurück zum Zitat Ravndal MEH, Borgwardt L, Juul K, Nielsen J, Borgwardt L, Henriksen BM et al (2021) Liver fibrosis in patients with tetralogy of Fallot, an unrecognised complication? Cardiol Young 31:1–11CrossRef Ravndal MEH, Borgwardt L, Juul K, Nielsen J, Borgwardt L, Henriksen BM et al (2021) Liver fibrosis in patients with tetralogy of Fallot, an unrecognised complication? Cardiol Young 31:1–11CrossRef
16.
Zurück zum Zitat Yamamura K, Sakamoto I, Morihana E, Hirata Y, Nagata H, Yamasaki Y et al (2019) Elevated non-invasive liver fibrosis markers and risk of liver carcinoma in adult patients after repair of tetralogy of Fallot. Int J Cardiol 287:121–126CrossRefPubMed Yamamura K, Sakamoto I, Morihana E, Hirata Y, Nagata H, Yamasaki Y et al (2019) Elevated non-invasive liver fibrosis markers and risk of liver carcinoma in adult patients after repair of tetralogy of Fallot. Int J Cardiol 287:121–126CrossRefPubMed
17.
Zurück zum Zitat Schleiger A, Salzmann M, Kramer P, Danne F, Schubert S, Bassir C et al (2020) Severity of Fontan-associated liver disease correlates with fontan hemodynamics. Pediatr Cardiol 41(4):736–746CrossRefPubMedPubMedCentral Schleiger A, Salzmann M, Kramer P, Danne F, Schubert S, Bassir C et al (2020) Severity of Fontan-associated liver disease correlates with fontan hemodynamics. Pediatr Cardiol 41(4):736–746CrossRefPubMedPubMedCentral
18.
Zurück zum Zitat Udholm S, Aldweib N, Hjortdal VE, Veldtman GR (2018) Prognostic power of cardiopulmonary exercise testing in Fontan patients: a systematic review. Open Heart 5(1):e000812CrossRefPubMedPubMedCentral Udholm S, Aldweib N, Hjortdal VE, Veldtman GR (2018) Prognostic power of cardiopulmonary exercise testing in Fontan patients: a systematic review. Open Heart 5(1):e000812CrossRefPubMedPubMedCentral
19.
Zurück zum Zitat Heye T, Yang SR, Bock M, Brost S, Weigand K, Longerich T et al (2012) MR relaxometry of the liver: significant elevation of T1 relaxation time in patients with liver cirrhosis. Eur Radiol 22(6):1224–1232CrossRefPubMed Heye T, Yang SR, Bock M, Brost S, Weigand K, Longerich T et al (2012) MR relaxometry of the liver: significant elevation of T1 relaxation time in patients with liver cirrhosis. Eur Radiol 22(6):1224–1232CrossRefPubMed
20.
Zurück zum Zitat Luetkens JA, Klein S, Träber F, Block W, Schmeel FC, Sprinkart AM et al (2019) Quantification of liver fibrosis: extracellular volume fraction using an MRI bolus-only technique in a rat animal model. Eur Radiol Exp 3(1):22CrossRefPubMedPubMedCentral Luetkens JA, Klein S, Träber F, Block W, Schmeel FC, Sprinkart AM et al (2019) Quantification of liver fibrosis: extracellular volume fraction using an MRI bolus-only technique in a rat animal model. Eur Radiol Exp 3(1):22CrossRefPubMedPubMedCentral
21.
Zurück zum Zitat Ingle L, Cleland JG, Clark AL (2014) The long-term prognostic significance of 6-minute walk test distance in patients with chronic heart failure. Biomed Res Int 2014:505969CrossRefPubMedPubMedCentral Ingle L, Cleland JG, Clark AL (2014) The long-term prognostic significance of 6-minute walk test distance in patients with chronic heart failure. Biomed Res Int 2014:505969CrossRefPubMedPubMedCentral
22.
Zurück zum Zitat Arslan S, Erol MK, Gundogdu F, Sevimli S, Aksakal E, Senocak H et al (2007) Prognostic value of 6-minute walk test in stable outpatients with heart failure. Tex Heart Inst J 34(2):166–169PubMedPubMedCentral Arslan S, Erol MK, Gundogdu F, Sevimli S, Aksakal E, Senocak H et al (2007) Prognostic value of 6-minute walk test in stable outpatients with heart failure. Tex Heart Inst J 34(2):166–169PubMedPubMedCentral
23.
Zurück zum Zitat Niedeggen A, Skobel E, Haager P, Lepper W, Mühler E, Franke A (2005) Comparison of the 6-minute walk test with established parameters for assessment of cardiopulmonary capacity in adults with complex congenital cardiac disease. Cardiol Young 15(4):385–390CrossRefPubMed Niedeggen A, Skobel E, Haager P, Lepper W, Mühler E, Franke A (2005) Comparison of the 6-minute walk test with established parameters for assessment of cardiopulmonary capacity in adults with complex congenital cardiac disease. Cardiol Young 15(4):385–390CrossRefPubMed
24.
Zurück zum Zitat Ghelani SJ, Lu M, Sleeper LA, Prakash A, Castellanos DA, Clair NS et al (2022) Longitudinal changes in ventricular size and function are associated with death and transplantation late after the Fontan operation. J Cardiovasc Magn Reson 24(1):56CrossRefPubMedPubMedCentral Ghelani SJ, Lu M, Sleeper LA, Prakash A, Castellanos DA, Clair NS et al (2022) Longitudinal changes in ventricular size and function are associated with death and transplantation late after the Fontan operation. J Cardiovasc Magn Reson 24(1):56CrossRefPubMedPubMedCentral
Metadaten
Titel
Significantly elevated hepatic extracellular volume in adult patients with a Fontan circulation and its correlation with impaired functional capacity
verfasst von
Surachai Kongrat
Tananya Lueangklanlayanakhun
Varinsawat Prakongwong
Watcharee Prasertkulchai
Tarinee Tangcharoen
Publikationsdatum
02.11.2023
Verlag
Springer Netherlands
Erschienen in
The International Journal of Cardiovascular Imaging / Ausgabe 1/2024
Print ISSN: 1569-5794
Elektronische ISSN: 1875-8312
DOI
https://doi.org/10.1007/s10554-023-02969-w

Weitere Artikel der Ausgabe 1/2024

The International Journal of Cardiovascular Imaging 1/2024 Zur Ausgabe

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

29.05.2024 Herzinfarkt Nachrichten

Bei Menschen mit Typ-2-Diabetes sind die Chancen, einen Myokardinfarkt zu überleben, in den letzten 15 Jahren deutlich gestiegen – nicht jedoch bei Betroffenen mit Typ 1.

Erhöhtes Risiko fürs Herz unter Checkpointhemmer-Therapie

28.05.2024 Nebenwirkungen der Krebstherapie Nachrichten

Kardiotoxische Nebenwirkungen einer Therapie mit Immuncheckpointhemmern mögen selten sein – wenn sie aber auftreten, wird es für Patienten oft lebensgefährlich. Voruntersuchung und Monitoring sind daher obligat.

GLP-1-Agonisten können Fortschreiten diabetischer Retinopathie begünstigen

24.05.2024 Diabetische Retinopathie Nachrichten

Möglicherweise hängt es von der Art der Diabetesmedikamente ab, wie hoch das Risiko der Betroffenen ist, dass sich sehkraftgefährdende Komplikationen verschlimmern.

TAVI versus Klappenchirurgie: Neue Vergleichsstudie sorgt für Erstaunen

21.05.2024 TAVI Nachrichten

Bei schwerer Aortenstenose und obstruktiver KHK empfehlen die Leitlinien derzeit eine chirurgische Kombi-Behandlung aus Klappenersatz plus Bypass-OP. Diese Empfehlung wird allerdings jetzt durch eine aktuelle Studie infrage gestellt – mit überraschender Deutlichkeit.

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.